Treatment of 37 patients with anaplastic carcinoma of the thyroid.
about
Long-term results of radiotherapy in anaplastic thyroid cancerRadiotherapy planning techniques for thyroid cancer.Anaplastic thyroid carcinoma: a therapeutic dilemma.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancersRecurrent and/or metastatic thyroid cancer: therapeutic options.Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.Anaplastic thyroid carcinomaPrognostic factors of anaplastic thyroid carcinoma.Poorly differentiated and anaplastic thyroid cancer.Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer.Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.Anaplastic thyroid carcinoma: a 25-year single-institution experience.Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the Anaplastic Thyroid Carcinoma Research Consortium of Japan database.Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests.Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma.Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.
P2860
Q30317480-87640B5E-51C2-475C-9EAE-46F252A35414Q33598373-1FEB07A7-97C9-4B59-AB38-25A7A833C4A0Q33607173-36A2B7AF-C214-476F-9C88-5A5204884F1EQ33691759-FF1D8155-2531-467C-8C58-46A36525DA98Q34123724-A0E1D767-76B6-465D-8CFF-2F6F755D2100Q34706919-77F67879-8877-4227-BBD1-6E4647524FF6Q35000792-1DF22FF5-0D84-46D7-9E90-5173105EE5BCQ35824783-7204D588-BDF0-45C3-896B-0FBF4FDE843FQ36075843-9A24023C-4CCD-4970-ADC0-52B9C88B3D95Q36428222-9517657B-49AD-445B-930C-F7554A29FFDBQ36493228-8A87D639-BC82-4F29-A7BF-1A11573B80F7Q36885846-6C084B8F-A8C1-419E-937D-78100AABB4A3Q37209593-BCE97ABC-2FD8-4B6B-BEE8-B5E2A8165BC1Q37526750-02563EC2-E091-4C31-90BE-48E23194FD21Q38189700-509E727F-4AC6-4548-96DE-CBCE777BDF36Q38217116-2A286DC0-FF54-4CA9-89BF-F7489A9F3395Q38657760-BDB850EB-7A19-481C-9854-AF99FDF548F2Q39984567-87AF1FD6-1B9B-4AD1-827F-FF653EF5D59DQ45005011-ECF712F7-9CC0-423A-A77B-F39716A75537Q46808686-E4490CBC-AAF0-4263-9DB7-CD13AD01FA11Q47631967-272B3918-446E-4A39-8C52-FAD6A2937201Q55018380-017EAA47-86E2-4323-9003-9F51EA5BEC64Q55712413-B5705A51-C264-4393-9A1E-271F68E1F4B2
P2860
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@en
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@nl
type
label
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@en
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@nl
prefLabel
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@en
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@nl
P2093
P2860
P1433
P1476
Treatment of 37 patients with anaplastic carcinoma of the thyroid.
@en
P2093
Kobayashi T
Maruyama H
Matsuzuka F
Umeshita K
P2860
P356
10.1002/(SICI)1097-0347(199601/02)18:1<36::AID-HED5>3.0.CO;2-#
P577
1996-01-01T00:00:00Z